chrisvoncsefalvay/vaers-outcomes huggingface dataset:
lymphadenopathy along the left collar bone; This is a spontaneous report from a contactable other hcp (patient).  This 60-Year-old female no pregnant patient received,at hospital, the second dose of BNT162B2 PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) from lot# EL3246 on left arm  on 14Jan2021 07:30 at SINGLE DOSE for covid-19 immunisation .  The patient medical history was not reported.  The patient's concomitant medications were not reported.  No other vaccine in four weeks.The patient previously took ibuprofen and experienced drug hypersensitivity.First dose details : lot number=EK9231,administration date= 24Dec2020,administration time= 07:30 AM,vaccine location= Left arm,dose number= 1.The patient experienced lymphadenopathy along the left collar bone on 16Jan2021 06:00 .No treatment received.Event outcome was not recovered.  No covid prior vaccination,No covid tested post vaccination.
High fever, headache, diagnosed with pneumonia. Received an antibiotic shot and two prescriptions of different antibiotics. Still experience fatigue and feel unwell most days.
Patient had likely vasovagal reaction. Mom came  back to consult window stating her daughter wasn't feeling well and feeling faint, trouble breathing. called 911.  Once pt seated she stated she started to feel faint, dizzy, seing bright light. Lips started turing purple. This occured about 4-5 min after receiving vaccine. Her breathing improved, had EPIPEN to inject just incase, but Paramedics arrived.
Hive-like rash extended from deltoid to underarm approx. 3 cm x 17 cm. Pain radiated from (R) deltoid to (R) shoulder.
Extreme cramping and vomiting on first day of menstrual cycle.  Still occurs on first day of menstrual cycle each month.  Had never happened prior to receiving vaccine.
Shortness of breath; Joint pain; fatigue; headache; ribs pain; chest pressure; burning feeling of my eyes; This is a spontaneous report from a contactable healthcare professional reporting for herself. A 51-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number/expiration date: not provided), via an unspecified route of administration, on 04Jan2021 03:45 PM (at the age of 51 years old) as a single dose in the left arm for COVID-19 vaccination. Relevant medical history included prior to the vaccination, the patient was diagnosed with COVID-19 on an unknown date. The patient did not have any known allergies to medications, food, or other products. Concomitant medication (other medications taken in two weeks) were none. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 05Jan2021, at 05:00 AM, the patient experienced shortness of breath, joint pain, headache, fatigue, ribs pain, chest pressure and burning feeling of her eyes. Treatment received for the events included an inhaler and acetaminophen (TYLENOL). The outcome of the events shortness of breath, joint pain, headache, fatigue, ribs pain, chest pressure and burning feeling of her eyes was recovering. Since the vaccination, the patient had not been tested for COVID-19.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up.
A 63 year old man received Tice BCG as an initial series of 6 weekly instillations and a series of 3 weekly instillations given 3 months later.  Following the last of these initial 9 instillations, he experienced hematuria with clots which lasted for 4-6 hours.  Due to the hematuria, he was given 2 instillations of 1/4 strength Tice BCG.  Since receiving the last instillations, he has experienced a "low grade apididymitis", recurrence of prostatitis, and also urethral discomfort after voiding which he describes as "urethritis".  No prostate or epididymal cultures have been obtained.  Treatment with tamsulosin.
Rashes developed on neck and upper torso, light headedness and nausea that persisted until 1/7/2021
Pfizer BioNTech COVID-19 Vaccine EUA: Patient received four total doses Patient received Pfizer Vaccines on 4/13/2021, 5/4/2021 From Pharmacy and on 9/9/2021 as well as 9/30/2021 from Facility.
(R) arm swelling - redness/pain temp 99.5. Received PNEUMOVAX 1/23/18 at PCP office.
I had pain in the arm after the 4 days; slight headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received BNT162b2 (BNT162B2), in 2021 as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "ongoing allergy problems/allergies" (ongoing), notes: I have medical problems and allergies/ongoing allergy problems. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), administration date: 2021, for COVID-19 immunization. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 2021, 4 days after the suspect product(s) administration, outcome "unknown", described as "I had pain in the arm after the 4 days"; HEADACHE (non-serious) with onset 2021, outcome "unknown", described as "slight headache".  Additional information: it was reported as the patient wanted to get the Pfizer COVID-19 booster for adults. I have not been able to get it for ongoing allergy problems. My pharmacist said I have to wait until I'm not flaring up. I would assume this is accurate. Additionally, I'm trying to find out with the ingredients of the new Pfizer booster that I might have an adverse reaction to. The pharmacy said I need to have another two boosters to get the new booster. The caller requested information on whether flaring allergies are a contraindication for the Pfizer-BioNTech COVID-19 vaccine, Bivalent.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Moderna COVID-19 Vaccine  Started with every joint and muscle aching, fever, nausea, headache, hair shedding at a high rate.  I was sick for over 36 hours and I am currently still loosing hair.  I will not be getting the 2nd vaccine.  I tested positive for COVID on December 19, 2020.  I was not expecting to get so sick wit the first shot.  I'm completely afraid to take the second shot.
This spontaneous report as received from a pharmacist refers to a 73 year old female patient with no pertinent medical history and no known drug reactions/allergies. It was reported that on 11-MAY-2015 the patient was vaccinated with a second dose of PNEUMOVAX23, lot # K005402 and expiration date on 07-NOV-2015. The first dose was administered "many years ago" according to reporter. Concomitant medications included levofloxacin, albuterol sulfate (manufacturer unknown). promethazine, codeine and pravastatin. The reporter stated that patient began to experience on 11-MAY-2015 soreness in the inject arm shortly following the administration. A the time of the report, the patient was still experiencing soreness in the injection arm. The patient did not receive any treatment for the event. No laboratory test was performed. The patient sought medical attention by calling the physician and the pharmacy. The relatedness between the event and suspect therapy was not provided. Additional information has been requested.
Nausea; sore arm; fever; This is a spontaneous report from a contactable healthcare professional.  A 54-year-old female patient received second dose of  BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL 3246), via an unspecified route of administration on the right arm on 02Feb2021 08:15 at single dose for COVID-19 immunisation.  Medical history allergies: pcn, latex, wheat/gluten, dairy, soy, corn.  The patient's concomitant medications were not reported.  The patient previously took first dose of BNT162B2 (lot number: EL 3246) on 11Jan2021 06:30 PM on the right arm for covid-19 immunisation; epinephrine and experienced allergies.  At 6:00 PM on 02Feb2021, patient developed fever 99.4 and steadily rose to 101.5 by 9:30 PM; sore arm all day and night, following day much less sore and easier to move.  Fever stayed overnight, down to 100.5 morning on 03Feb2021.  Nausea accompanied fever and still have slight nausea. The patient received no treatment. The outcome of the events was recovering.
Sever hair lose on head diagnosed as Alopecia Areata Totalis.  Almost total loss as of  this writing.  There is no known reason for this to have happen; therefore, the vaccine is a suspect.
This spontaneous report was received from a healthcare worker and refers to an unspecified number of patients of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions, allergies or concomitant therapies was provided. On unknown dates, the patients were vaccinated with improperly stored doses of PROQUAD (lot # reported as M006105, expiration date 01-AUG-2017, exact doses and route of administration were not reported). The reason of the call was temperature alarm received via Digital Logger. It was reported that the vaccines were exposed to temperature of 9.6 Celsius degrees for 1 hour before administration to the patients. No previous temperature excursion was reported. No adverse effect were reported. This is one of several reports received from the same source. Additional information has been requested.
Local pain/swelling at site of SC PNEUMOVAX injection x 24 hours, then developed significant pain, (+) fevers at home and arm with spreading erythema that extended just proximal to elbow. She was seen at a local UC and diagnosed with cellulitis of LUE, placed on KEFLEX.
ended up in hospital; This case was reported by a consumer via interactive digital media and described the occurrence of hospitalization in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, 1 day after receiving Shingles vaccine, the patient experienced hospitalization (serious criteria hospitalization). On an unknown date, the outcome of the hospitalization was unknown.   It was unknown if the reporter considered the hospitalization to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 13-JUL-2022 Reporter's Comments: This case was reported by patient via interactive digital media. The patient received first dose of Shingles vaccine and next day ended up in hospital. Additional supportive information: The follow-up would not possible as no contact details were available.
feeling like was about to pass out; difficulty breathing and shortness of breath; Weakness; arm pain and foot pain; Malaise; Right side pain/Pain on my right side of my body; Arthritis pain; dizziness; Heart palpitations; chills; Joint Pain; Exhaustion/tired/No energy; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PRESYNCOPE (feeling like was about to pass out), DYSPNOEA (difficulty breathing and shortness of breath), ASTHENIA (Weakness), PAIN IN EXTREMITY (arm pain and foot pain) and MALAISE (Malaise) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced PRESYNCOPE (feeling like was about to pass out), DYSPNOEA (difficulty breathing and shortness of breath), ASTHENIA (Weakness), PAIN IN EXTREMITY (arm pain and foot pain), MALAISE (Malaise), PAIN (Right side pain/Pain on my right side of my body), ARTHRITIS (Arthritis pain), DIZZINESS (dizziness), PALPITATIONS (Heart palpitations), CHILLS (chills), ARTHRALGIA (Joint Pain), FATIGUE (Exhaustion/tired/No energy) and HEADACHE (Headache). At the time of the report, PRESYNCOPE (feeling like was about to pass out), DYSPNOEA (difficulty breathing and shortness of breath), ASTHENIA (Weakness), PAIN IN EXTREMITY (arm pain and foot pain), MALAISE (Malaise), PAIN (Right side pain/Pain on my right side of my body), ARTHRITIS (Arthritis pain), DIZZINESS (dizziness), PALPITATIONS (Heart palpitations), CHILLS (chills), ARTHRALGIA (Joint Pain), FATIGUE (Exhaustion/tired/No energy) and HEADACHE (Headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant and treatment medications were reported. Patient was reported to still have headache, asthenia, shortness of breath, fatigue and pain. She was reported to have sought doctor's consultation.   Most recent FOLLOW-UP information incorporated above includes: On 16-Jun-2021: Follow up was received on 16-JUN-2021. Physician office visit was checked. Patient's events status information was added in inarrative supplement.
Anxiety, nausea, vomiting. Pt. complained of anxiety after receiving the 2nd dose of Pfizer vaccine.  Pt. observed vomiting clear emesis with mild discomfort.  Emergency personnel notified and pt. refused transport for further evaluation.
Initial report received on 14 February 2007 from a health care professional. A 35-year-old female patient , who had no illnesses, and a past medical history of allergy to gluten and nitrous oxide, had received a 0.1 ml, intradermal, left forearm, injection of Adacel, lot number C2556AA, on 11 February 2007. Intradermal injection of Adacel is not a recommended route of administration by the manufacturer. The patient was supposed to receive Tubersol intradermally instead of Adacel. Two days post-vaccination, the patient experienced redness, blisters, and 14 mm induration at the injection site. At the time of this report, the patient had not recovered.
Red ring around injection site, soreness, swelling & hot to the touch. Patient told to take TYLENOL for pain if needed.
Information has been received from a physician concerning a 15-month-old white male with no medical history who on 07-Nov-2003 was vaccinated SC in the left thigh with the first dose of varicella virus vaccine live. Concomitant vaccinations on that same day included the third dose IM in the right thigh of hepatitis B virus vaccine rHBsAg (yeast) (Lot #645479/0215N) and the first dose SQ in the right thigh of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine (Lot #645406/0133N). There was no illness at the time of vaccination. The physician reported that on 12-Nov-2003, the patient developed a severe varicella rash. Medical attention was not sought and no laboratory diagnostic tests were performed. At the time of this report, the outcome was unknown. Additional information has been requested.
The day after the injection the area around it started to look red and raised.  the next day it had spread down my uper front half and underarm almost to the elbow and started to itch mildly. I am now 4 days out from the initial symptoms and it is still reddish but fading in spots.  The itching has continued but is mild. I have pictures she took and pictures I took and they look almost identical.  I called my primary care and the nurse assured me that it was common and would abate in a week.  I took antihistamine for two nights.
Itchy my whole body, body aches and joint, bumps full of pus and once explode leave scars.
Pt first received the Nexplanon implant and then about 5 min after received her flu vaccine.   Immediately after receiving the flu vaccine she fainted and then had a seizure that lasted 15-20 seconds. Pt was transported by EMS to the emergency room and was later cleared and sent home.
Here's what I know about the vaccine: SHINGRIX, zoster vacc recombinant adjuvanted IM inj. I have a headache, muscle and joint aches, and lethargy.
Pt received Pediarix (DTaP-HepB-IPV) and Pentocel (Hib-DTaP-IPV) rather than Pediarix and ActHib.  No clinical problems noted for the infant.
Elevated temp of 103.8 pt given APAP for fever; rash other than @ inject site, ill for 3 days;
Pt recvd vax &  exp malaise & myalgia but sx persisted for only 1 wk;
Tingling in right foot day following vaccination as if my foot was falling asleep constant for about 6 weeks. At roughly 6 weeks post vaccination, numbness spread up my right leg and to my arm and hands. This lasted for approximately 72 hours. When this subsided, tingling in right foot returned but is now intermittent and mild 3 months post vaccination.
Diarrhea; Vomited; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) and VOMITING (Vomited) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. UNKNONWN) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (Diarrhea) and VOMITING (Vomited). At the time of the report, DIARRHOEA (Diarrhea) and VOMITING (Vomited) outcome was unknown.            No concomitant medications reported. No treatment medications reported.
Patient had 4 days of fever, max 103, dehydration, cervical lymphadenopathy and elevated inflammatory markers. His ESR was elevated to 120 and CRP was 8. Was found to have microcytic anemia Hgb 10, MCV 63
Itching, turning red and feverish on the site of the injection; Itching, turning red and feverish on the site of the injection; Feverish; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itching, turning red and feverish on the site of the injection), VACCINATION SITE ERYTHEMA (Itching, turning red and feverish on the site of the injection) and PYREXIA (Feverish) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included FOLIC ACID for an unknown indication.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (Itching, turning red and feverish on the site of the injection), VACCINATION SITE ERYTHEMA (Itching, turning red and feverish on the site of the injection) and PYREXIA (Feverish). The patient was treated with CALAMINE, GLYCEROL, ZINC OXIDE (CALAMINE LOTION) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PRURITUS (Itching, turning red and feverish on the site of the injection), VACCINATION SITE ERYTHEMA (Itching, turning red and feverish on the site of the injection) and PYREXIA (Feverish) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication included  Centroid.  The patient was holding a cold pack on her arm.
Consistent heart palpitations and tachycardia 48 hours post-vaccine Dyspnea with and without exertion 48 hours post-vaccine Unable to perform duties as RN since the vaccination
Dizziness and shortness of breath approximately 15 minutes after the vaccine was administered.  Attendee monitored, EMS was called and she was evaluated.  Refused transport. O2 Saturation 98-99% via EMS on Room air.  3 sets of vital signs taken prior to EMS arriving, that were within normal limits. respiratory rate was 18 for the duration of the extended monitoring.
I had a flu shot don't know which one or manufacture. Woke up 10/30 to bad hives all over body still not gone as of today actually worse 11/1
Warmth at injection site; Swelling at injection site; Redness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (Warmth at injection site), INJECTION SITE SWELLING (Swelling at injection site) and INJECTION SITE ERYTHEMA (Redness at injection site) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No medical history was provided by the reporter. .  Concomitant products included LISINOPRIL, HYDROCHLOROTHIAZIDE, FLUOXETINE, MONTELUKAST SODIUM (SINGULAIR), LORATADINE, ZOLPIDEM TARTRATE (AMBIEN), ATORVASTATIN, VITAMIN D NOS and VITAMIN D3 for an unknown indication.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, the patient experienced INJECTION SITE WARMTH (Warmth at injection site), INJECTION SITE SWELLING (Swelling at injection site) and INJECTION SITE ERYTHEMA (Redness at injection site). At the time of the report, INJECTION SITE WARMTH (Warmth at injection site), INJECTION SITE SWELLING (Swelling at injection site) and INJECTION SITE ERYTHEMA (Redness at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was reported.
Diarrhea; Incontinence of urine; Sweating; Aches and pains; 98.9 degree fever; This spontaneous case was reported by a nurse and describes the occurrence of DIARRHOEA (Diarrhea), URINARY INCONTINENCE (Incontinence of urine), HYPERHIDROSIS (Sweating), PAIN (Aches and pains) and PYREXIA (98.9 degree fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 034F21A, 007M20A and 011L20A) for COVID-19 vaccination.     The patient's past medical history included Bypass surgery (two triple bypasses). Concurrent medical conditions included Cardiac disorder NOS. Concomitant products included ASPIRIN [ACETYLSALICYLIC ACID], METOPROLOL TARTRATE (LOPRESSOR), ISOSORBIDE MONONITRATE, ROSUVASTATIN CALCIUM (CRESTOR) and TAMSULOSIN HCL for an unknown indication.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Nov-2021, the patient experienced DIARRHOEA (Diarrhea), URINARY INCONTINENCE (Incontinence of urine), HYPERHIDROSIS (Sweating), PAIN (Aches and pains) and PYREXIA (98.9 degree fever). At the time of the report, DIARRHOEA (Diarrhea), URINARY INCONTINENCE (Incontinence of urine), HYPERHIDROSIS (Sweating), PAIN (Aches and pains) and PYREXIA (98.9 degree fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Nov-2021, Body temperature: 98.9 (High) 98.9 degree Celsius.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment medications were provided.  It was reported that the patient was not taking his regular medication because of these symptoms.
Information has been received from a physician concerning a patient who was vaccinated with a dose of GARDASIL on an unspecified date. Subsequently the patient fainted two seconds after the needle was removed from the patient. The reporter felt that fainting two seconds after needle removed was not related to therapy with GARDASIL. Follow-up information has been received from a medical assistant concerning an 11 year old female who on 22-JUL-2009 was vaccinated with the first dose of GARDASIL (lot#661531/1311X). Concomitant vaccination on the same day included a dose of MENACTRA. It was reported that after the needle was removed, the patient fainted and slumped over onto the medical assistant. The patient came right to. It was noted that they waited for a little bit and then the doctor administered the MENACTRA. The medical assistant also reported that the patient's parent did not call back, so she assumed that the patient was okay, had recovered at the time of the report. Additional information has been requested. This is one of several reports from the same source.